ORELVO Trademark Information

Aurinia Pharmaceuticals Inc.

Pharmaceutical preparations for the treatment of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus nephritis

Perfect for these industries

Words that describe this mark

pharmaceutical   preparations   treatment   autoimmune   disorders     kidney   disorders     opthamalogical   disorders   lupus   nephritis  

This is a brand page for the ORELVO trademark by Aurinia Pharmaceuticals Inc.  in V8Z 7X8, , .

Write a review about a product or service associated with this ORELVO trademark. Or, contact the owner Aurinia Pharmaceuticals Inc. of the ORELVO trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the ORELVO trademark.

Status Update! On Monday, February 10, 2020, status on the ORELVO trademark changed to RESPONSE AFTER NON-FINAL ACTION - ENTERED.

On Tuesday, September 12, 2017, a U.S. federal trademark registration was filed for ORELVO. The USPTO has given the ORELVO trademark serial number of 87604397. The current federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED. The correspondent listed for ORELVO is MATTHEW R. WILMOT of STOEL RIVES LLP, 760 SW NINTH AVENUE, SUITE 3000, PORTLAND OR 97205 . The ORELVO trademark is filed in the category of Pharmaceutical Products . The description provided to the USPTO for ORELVO is Pharmaceutical preparations for the treatment of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus nephritis.

Word mark: ORELVO
Status/Status Date:
RESPONSE AFTER NON-FINAL ACTION - ENTERED
2/10/2020
Serial Number: 87604397
Filing Date: 9/12/2017
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical preparations for the treatment of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus nephritis
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: N/A
Last Applicant/Owner: Aurinia Pharmaceuticals Inc.
V8Z 7X8
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
STOEL RIVES LLP
760 SW NINTH AVENUE, SUITE 3000
PORTLAND OR 97205

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your ORELVO trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Starting $199/class + govt fees! Click here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner.
Current Trademark Status:
2/10/2020
RESPONSE AFTER NON-FINAL ACTION - ENTERED
Correspondent Search:

MATTHEW R. WILMOT is a correspondent of ORELVO trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do: